CNBC's Becky Quick to Moderate CEO Leadership Dialogue on the Next Decade of Rare Disease at the NORD Breakthrough Summit

Summary

NORD announced a CEO leadership dialogue on rare disease innovation at the NORD Breakthrough Summit, featuring executives from BioMarin, Jazz Pharmaceuticals, and Otsuka Pharmaceutical, moderated by CNBC's Becky Quick.